Pharma News, 2018

PHILADELPHIA, Oct.

LONDON (Reuters) - The number of new clinical trials started in Britain last year was 25 percent lower than the average for 2009-16, as anxiety about Brexit’s impact on future medicines regu...

Celltrion’s biosimilar to Roche’s blockbuster Rituxan has already been rejected at the FDA once for manufacturing problems, but in the company’s second attempt, agency staffers have reacted favo...

SHANGHAI (Reuters) - China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said on Wednesday, part of its efforts to make cancer treatme...

GlaxoSmithKline awarded its estimated $1.

For the first time, scientists have been able to image brain activity when people change their short-term beliefs, and to relate this brain activity to dopamine function in humans.

Veracyte, Inc.

Lobsor Pharmaceuticals AB is considering an initial public offering to supercharge European expansion after its Parkinson’s treatment was just approved by the Swedish Medical Products Agency.

Both EV-D68 and EV-A71 are enteroviruses, and they are in the same family of viruses as polio.

Currently, ciprofloxocin is often used to treat infections of the genitourinary system, ear disorders and flu.

(Reuters) - Bausch Health Cos Inc, formerly Valeant Pharmaceuticals, said on Monday it received tentative U.

Akcea and Ionis’ Tegsedi has won US approval for patients with hereditary transthyretin amyloidosis (hATTR), a rare disease causing build up of amyloid in the peripheral nervous system and m...